Sands Capital Ventures, LLC Long-Term Concentrated

CIK: 0001846444 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 13, 2025

Total Value ($000): $507,820 (100.0% shares, 0.0% debt)

Holdings (19)

KVYO KLAVIYO INC 23.2%
Value ($000) $118,036 Shares 3,515,065 Est. Cost $27.81 Unrealized +13.9%
NU NU HLDGS LTD 19.4%
Value ($000) $98,447 Shares 7,175,434 Est. Cost $10.60 Unrealized +13.0%
DASH DOORDASH INC 18.5%
Value ($000) $93,970 Shares 381,202 Est. Cost $191.28 Unrealized +4.9%
BBNX BETA BIONICS INC 10.2%
Value ($000) $51,981 Shares 3,570,113 Est. Cost $18.06 Unrealized -21.6%
CPNG COUPANG INC 5.0%
Value ($000) $25,437 Shares 849,031 Est. Cost $24.45 Unrealized +4.8%
IKT INHIBIKASE THERAPEUTICS INC 4.2%
Value ($000) $21,353 Shares 10,950,000 Est. Cost $2.49 Unrealized -21.5%
MNDY MONDAY COM LTD 3.6%
Value ($000) $18,346 Shares 58,336 Est. Cost $276.85 Unrealized +0.6%
IOT SAMSARA INC 3.4%
Value ($000) $17,443 Shares 438,485 Est. Cost $45.34 Unrealized -8.8%
DDOG DATADOG INC 3.1%
Value ($000) $15,946 Shares 118,707 Est. Cost $134.86 Unrealized -17.9%
CRWD CROWDSTRIKE HLDGS INC 1.6%
Value ($000) $7,953 Shares 15,615 Est. Cost $330.02 Unrealized +31.4%
TOST TOAST INC 1.4%
Value ($000) $6,936 Shares 156,604 Est. Cost $34.83 Unrealized +12.8%
TARS TARSUS PHARMACEUTICALS INC 1.4%
Value ($000) $6,887 Shares 170,000 Est. Cost $24.75 Unrealized +81.8%
SNOW SNOWFLAKE INC 1.2%
Value ($000) $6,043 Shares 27,005 Est. Cost $284.41 Unrealized -36.4%
TXG 10X GENOMICS INC 1.1%
Value ($000) $5,579 Shares 481,770 Est. Cost $51.88 Unrealized -82.4%
ABOS ACUMEN PHARMACEUTICALS INC 0.8%
Value ($000) $3,964 Shares 3,417,075 Est. Cost $16.64 Unrealized -93.5%
BIOA BIOAGE LABS INC 0.6%
Value ($000) $3,248 Shares 786,353 Est. Cost $20.04 Unrealized -79.9%
ACRV ACRIVON THERAPEUTICS INC 0.5%
Value ($000) $2,526 Shares 2,122,605 Est. Cost $11.67 Unrealized -88.2%
CADL CANDEL THERAPEUTICS INC 0.4%
Value ($000) $2,054 Shares 405,837 Est. Cost $8.29 Unrealized -37.9%
TSHA TAYSHA GENE THERAPIES INC 0.3%
Value ($000) $1,674 Shares 724,873 Est. Cost $19.01 Unrealized -88.6%